StockData
BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Biodexa Pharmaceuticals Plc

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026
$0.39−0.07 (-14.36%)

Close on Oct 19, 2026

Biodexa Pharmaceuticals Plc revenue by segment

No segment breakdown reported

Biodexa Pharmaceuticals does not break out revenue by segment, region or product in the tagged data of its filings for this period type.